AbCellera Biologics Inc.ABCLNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -31.01% |
| Q3 2025 | 13.52% |
| Q2 2025 | 15.30% |
| Q1 2025 | -0.50% |
| Q4 2024 | -13.99% |
| Q3 2024 | -4.48% |
| Q2 2024 | 12.60% |
| Q1 2024 | 8.61% |
| Q4 2023 | 6.94% |
| Q3 2023 | -7.88% |
| Q2 2023 | 2.42% |
| Q1 2023 | 20.37% |
| Q4 2022 | -6.96% |
| Q3 2022 | -3.71% |
| Q2 2022 | 5.37% |
| Q1 2022 | 13.05% |
| Q4 2021 | 17.85% |
| Q3 2021 | -0.08% |
| Q2 2021 | 38.87% |
| Q1 2021 | 12.13% |
| Q4 2020 | 123.32% |
| Q3 2020 | 75.75% |
| Q2 2020 | -2.01% |
| Q1 2020 | 44.37% |
| Q4 2019 | 45.38% |
| Q3 2019 | 26.54% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |